Literature DB >> 7924484

Gelatinolytic and type IV collagenolytic activity in bronchiectasis.

R Sepper1, Y T Konttinen, T Sorsa, H Koski.   

Abstract

To evaluate the extracellular matrix (ECM) degradation in bronchiectasis (BE), the level of gelatinolytic and type IV collagenolytic activity was analyzed in bronchoalveolar lavage fluid (BALF) by using zymographies. The BALF of patients with bronchiectasis revealed a high gelatinolytic and type IV collagenolytic activity whereas no such activities were detected in BALF of the healthy controls. Furthermore, the level of degradative activity correlated with the severity of disease with a spectrum varying from patients characterized by frequent pneumonia and bronchitis, mucopurulent and purulent sputum production, and saccular changes of bronchi having high activities of both 92-kd and 72-kd gelatinases type IV collagenases (corresponding to the neutrophil type MMP-9 and fibroblast type MMP-2 activities, respectively) to patients having few clinical symptoms and displaying only a weak activity at the 92-kd area. These findings suggest a role for the matrix metalloproteinases MMP-2 (72-kd gelatinase/type IV collagenase) and MMP-9 (92-kd gelatinase/type IV collagenase) in the degradation of ECM of bronchial wall and lung tissue. In addition, severe bronchiectasis was associated with the presence of low-molecular weight gelatinases reflecting in vivo metalloproteinase activation and/or the presence of microbial-derived gelatinolytic proteinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924484     DOI: 10.1378/chest.106.4.1129

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury.

Authors:  C A Herbert; M J Arthur; C Robinson
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

2.  Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.

Authors:  T Hayashi; W G Stetler-Stevenson; M V Fleming; N Fishback; M N Koss; L A Liotta; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

3.  Gelatinolytic activity in tracheal aspirates of horses with chronic obstructive pulmonary disease.

Authors:  A L Koivunen; P Maisi; Y T Konttinen; M Sandholm
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

4.  Collagenases and the serine proteinases elastase and cathepsin G in steroid-induced Pneumocystis carinii pneumonia.

Authors:  A Sukura; Y T Konttinen; R Sepper; L Kaartinen; T Sorsa; L A Lindberg
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 5.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

6.  Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.

Authors:  Bela M Arosalo; Marja Raekallio; Minna Rajamäki; Elina Holopainen; Tuulia Kastevaara; Hanna Salonen; Satu Sankari
Journal:  Acta Vet Scand       Date:  2007-01-23       Impact factor: 1.695

7.  Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis.

Authors:  Jifeng Liu; Xiaoning Zhong; Zhiyi He; Lianghong Wei; Xiaozhen Zheng; Jianquan Zhang; Jing Bai; Wei Zhong; Dengjun Zhong
Journal:  Mediators Inflamm       Date:  2014-11-04       Impact factor: 4.711

8.  Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan.

Authors:  Meng-Heng Hsieh; Pai-Chien Chou; Chun-Liang Chou; Shu-Chuan Ho; Wen-Ching Joa; Li-Fei Chen; Te-Fang Sheng; Horng-Chyuan Lin; Tsai-Yu Wang; Po-Jui Chang; Chun-Hua Wang; Han-Pin Kuo
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

9.  Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  David A Bergin; Killian Hurley; Adwait Mehta; Stephen Cox; Dorothy Ryan; Shane J O'Neill; Emer P Reeves; Noel G McElvaney
Journal:  J Inflamm Res       Date:  2013-01-23

10.  Activation of Tissue Remodeling Precedes Obliterative Bronchiolitis in Lung Transplant Recipients.

Authors:  Allan M Ramirez; David R Nunley; Mauricio Rojas; Jesse Roman
Journal:  Biomark Insights       Date:  2008-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.